- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patent holdings for IPC class A61P 31/00
Total number of patents in this class: 6567
10-year publication summary
|
173
|
278
|
369
|
320
|
418
|
411
|
408
|
332
|
278
|
65
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
275 |
| Bristol-myers Squibb Company | 4817 |
65 |
| The Regents of the University of California | 20473 |
43 |
| Centre National de La Recherche Scientifique | 10841 |
34 |
| Merck Patent GmbH | 5743 |
26 |
| Agency for Science, Technology and Research | 3682 |
26 |
| The Johns Hopkins University | 5796 |
23 |
| Boehringer Ingelheim International GmbH | 4571 |
22 |
| The General Hospital Corporation | 4810 |
22 |
| Novartis AG | 10467 |
21 |
| F. Hoffmann-La Roche AG | 7874 |
21 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
21 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3107 |
21 |
| The University of North Carolina at Chapel Hill | 2074 |
21 |
| Pfizer Inc. | 3383 |
20 |
| President and Fellows of Harvard College | 6069 |
20 |
| Takeda Pharmaceutical Company Limited | 2728 |
20 |
| Merck Sharp & Dohme Corp. | 2186 |
18 |
| AstraZeneca AB | 2823 |
17 |
| Incyte Corporation | 1048 |
16 |
| Other owners | 5815 |